Tag: FDA reporting
Olly Steele
19 March 2026
Serious Adverse Events: Reporting Procedures for Generic Drugs
Despite identical regulations, serious adverse events from generic drugs are drastically underreported compared to brand-name drugs. This gap in safety data puts patients at risk and undermines post-market monitoring systems.
Categories
Archives
Tag Cloud
prescription savings
dietary supplement
drug interactions
generic drugs
medication safety
health benefits
online pharmacy
drug safety
treatment
medication
side effects
ACE inhibitors
drug side effects
statin side effects
adverse drug reactions
asthma treatment
cancer treatment
science
medications
stigma